Although the cases included in model (2) were more prevalent in having APOE-e4 carriers and had a primary diagnosis of AD compared to those in model (1), the differences in the characteristics of the participants included in the models (1) and (2) do not undermine our conclusion; instead, they contribute to enhancing its robustness. This evidence concerns the gene APOE and Alzheimer disease.